Latest From CombiMatrix Corp.
Genetic information specialist Invitae is spreading into the reproductive health market with the proposed acquisition of two genetic testing companies that are focused on this area. The addition of Good Start Genetics and Combinatrix will enable Invitae to gain a foothold in the lucrative perinatal. Prenatal and neonatal testing markets. These deals bring the total number of acquisitions made by Invitae to three this year so far.
FDA Commissioner-nominee Scott Gottlieb was approved by the Senate HELP committee April 27, sending his confirmation to the full Senate. Written responses from Gottlieb to senators' questions provided in advance of the vote don't hold any big surprises, but they provide a view into priorities of the incoming official and the lawmakers, including quick user-fee reauthorization, resolving the lab-developed test oversight debate, off-label and "right-to-try" issues and post-market surveillance.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Deaths potentially linked to Chicago firm's supplements; Vitamin Shoppe in Costa Rica; another own-labeler has GMP problems; and funding boost for protein water firm.
- Antisense, Oligonucleotides
Drug Discovery Tools
- Nanotechnology, Chips, etc.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Gynecological, Urological
- Acacia Research-CombiMatrix
- North America
- Parent & Subsidiaries
- CombiMatrix Corp.
- Senior Management
Mark McDonough, Pres. & CEO
Scott R Burrell, CFO
Kim Leroux, VP, Billing & Reimbursement
Karen Warner, VP, Payer Access & Reimbursement
- Contact Info
Phone: (949) 753-0624
Irvine, CA 92618
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.